SCHEMBL23930834

SCHEMBL23930834

COC(=O)c1cnc(CCO)n1C

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
RAB9A P51151 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 1/20 0.42
CYP4A11 Q02928 3/20 0.36
CYP4F2 P78329 2/20 0.36
KDM4E B2RXH2 2/20 0.36
HRH3 Q9Y5N1 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2827620 0.87 SMN1; SMN2 (0.49) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL23930934 0.86 KMT2A (0.48) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL10288449 0.83 ALDH1A1 (0.58) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL2824661 0.82 SMN1; SMN2 (0.48) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL2825471 0.82 RAB9A (0.50) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL2825470 0.81 RAB9A (0.49) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL13141309 0.79 SMN1; SMN2 (0.46) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL2825380 0.79 SMN1; SMN2 (0.46) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL23422001 0.77 SMN1; SMN2 (0.41) ALOX15SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL2824616 0.76 SMN1; SMN2 (0.43) ALOX15SMN1; SMN2RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed